Protagenic Therapeutics (PTIX) 10-Q2011 Q3 Quarterly report

Filed: 14 Nov 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: absent, amended, amendment, Auditor, avoid, climate, complex, cumulative, exceeding, exemption, expediently, Fong, foregoing, formal, gave, indefinite, individual, iphone, issuable, Nathan, OTC, OTCQB, proceed, qualitative, quotation, recognized, recognizing, relieved, SEC, settle, simultaneously, suspension, tier, title, undiscounted, voluntary, written

Removed: absorb, adding, advantage, allocation, Alternatively, approved, arrangement, Australia, automated, backend, beneficiary, bundled, calendar, controlling, create, differentiation, dollar, efficiency, EITF, employ, employing, encourage, enhancement, enhancing, enterprise, evidence, flexibility, generating, identifying, improving, incurring, innovative, Interpretation, landline, leverage, low, LTV, mechanism, modality, multifaceted, objective, organic, permitted, President, primary, printing, proficient, prospecting, proxy, radio, retrenchment, single, solicitation, submission, suite, superseded, Sydney, today, traditionally, traffic, validating, validation, visitor, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PTIX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2011 (the "Report") by Atrinsic, Inc. ("Registrant"), each of the undersigned hereby certifies that, to the best of their knowledge:

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Registrant.

Date: November 14, 2011	/s/ Stuart Goldfarb
	Stuart Goldfarb
	Chief Executive Officer and Director Principal Executive Officer

Date: November 14, 2011	/s/ Nathan Fong
	Nathan Fong
	Chief Financial Officer
	Principal Financial Officer

A signed original of this written statement required by Section 906 has been provided to Atrinsic, Inc. and will be retained by Atrinsic, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.